321 related articles for article (PubMed ID: 22943868)
1. [Retinoblastoma regression patterns and results following chemo reduction and adjuvant therapy].
Xue K; Qian J; Yue H; Yuan YF; Zhang R
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):625-30. PubMed ID: 22943868
[TBL] [Abstract][Full Text] [Related]
2. Retinoblastoma regression patterns following chemoreduction and adjuvant therapy in 557 tumors.
Shields CL; Palamar M; Sharma P; Ramasubramanian A; Leahey A; Meadows AT; Shields JA
Arch Ophthalmol; 2009 Mar; 127(3):282-90. PubMed ID: 19273791
[TBL] [Abstract][Full Text] [Related]
3. Regression patterns in treated retinoblastoma with chemotherapy plus focal adjuvant therapy.
Ghassemi F; Rahmanikhah E; Roohipoor R; Karkhaneh R; Faegh A
Pediatr Blood Cancer; 2013 Apr; 60(4):599-604. PubMed ID: 23034769
[TBL] [Abstract][Full Text] [Related]
4. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
5. [Clinical therapeutic efficiency of chemoreduction and local therapy for children with retinoblastoma].
Qian J; Xue K; Gao YJ; Yuan YF; Shan HD; Bi YW
Zhonghua Yan Ke Za Zhi; 2010 Apr; 46(4):312-6. PubMed ID: 20654057
[TBL] [Abstract][Full Text] [Related]
6. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
8. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
[TBL] [Abstract][Full Text] [Related]
10. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
Abramson DH; Schefler AC
Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
[TBL] [Abstract][Full Text] [Related]
11. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
12. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
14. Tumor Regression Patterns in Retinoblastoma.
Zafar SN; Siddiqui SN; Zaheer N
J Coll Physicians Surg Pak; 2016 Nov; 26(11):896-899. PubMed ID: 27981923
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Demirci H; Eagle RC; Shields CL; Shields JA
Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
[TBL] [Abstract][Full Text] [Related]
16. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcome and regression patterns of retinoblastoma treated with systemic chemoreduction and focal therapy: A prospective study.
Chawla B; Jain A; Seth R; Azad R; Mohan VK; Pushker N; Ghose S
Indian J Ophthalmol; 2016 Jul; 64(7):524-9. PubMed ID: 27609166
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
[TBL] [Abstract][Full Text] [Related]
19. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
[TBL] [Abstract][Full Text] [Related]
20. Conservative treatments of intraocular retinoblastoma.
Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]